Pinney & Scofield’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.79M Hold
7,379
3.66% 9
2025
Q4
$7.93M Sell
7,379
-8
-0.1% -$7.65K 4.5% 8
2025
Q3
$5.64M Hold
7,387
3.5% 9
2025
Q2
$5.76M Buy
7,387
+11
+0.1% +$8.55K 3.9% 8
2025
Q1
$6.09M Hold
7,376
4.41% 8
2024
Q4
$5.69M Buy
+7,376
New +$6.11M 4.31% 6

Other funds holding LLY

Pinney & Scofield's LLY Position: Q1 2026 in Review

Pinney & Scofield held its Eli Lilly (LLY) position steady in Q1 2026 at 7,379 shares worth $6.79M. The position accounts for 3.66% of the portfolio, ranked #9.

Pinney & Scofield first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $7.93M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Pinney & Scofield held 7,379 shares of Eli Lilly worth $6.79M as of Q1 2026.
  • Pinney & Scofield left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 3.66% of Pinney & Scofield's portfolio in Q1 2026, its #9 holding.
  • Pinney & Scofield first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Pinney & Scofield's Eli Lilly position peaked at $7.93M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Pinney & Scofield's 13F filing for Q1 2026, filed 15 May 2026.